{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:23:43Z","timestamp":1783477423782,"version":"3.55.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Kidney Foundation"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The links between chronic kidney disease (CKD) and the high burden of cardiovascular disease remain unclear. We aimed to explore the association between selected inflammatory and angiogenic biomarkers, kidney function and long-term outcome in patients with an acute coronary syndrome (ACS) and to test the hypothesis that CKD status modifies this association.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 1293 ACS patients hospitalized between 2008 and 2015 were followed until 31 December 2017. Plasma was collected on days 1\u20133 after admission. A total of 13 biomarkers were a priori identified and analysed with two proteomic methods, proximity extension assay or multiple reaction monitoring mass spectrometry. Boxplots and multiple linear regression models were used to study associations between biomarkers and kidney function and adjusted standardized Cox regression with an interaction term for CKD was used to assess whether CKD modified the association between biomarkers and major adverse cardiovascular events and death (MACE+).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The concentrations of nine biomarkers\u2014endothelial cell-specific molecule-1 (ESM-1), fibroblast growth factor 23 (FGF-23), fractalkine (CX3CL1), interleukin-1 receptor antagonist (IL-1RA), interleukin-18 (IL-18), monocyte chemotactic protein-1 (MCP-1), placenta growth factor (PlGF), transmembrane immunoglobulin 1 (TIM-1) and vascular endothelial growth factor A (VEGFA)\u2014were inversely associated with kidney function. ESM-1, FGF-23 and TIM-1 showed associations with MACE+. Only FGF23 remained independently associated after adjustment for the other biomarkers (hazard ratio per standard deviation increase 1.34; 95% Bonferroni corrected confidence interval 1.19\u20131.50). None of the biomarkers showed an interaction with CKD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The concentrations of 9 of the 13 prespecified inflammatory and angiogenic proteomic biomarkers increased when kidney function declined. Only FGF-23 demonstrated an independent association with MACE+, and this association was not modified by CKD status. These findings further support FGF-23 as an independent prognostic marker in ACS patients with and without CKD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfae050","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T22:04:50Z","timestamp":1709244290000},"source":"Crossref","is-referenced-by-count":5,"title":["Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function"],"prefix":"10.1093","volume":"17","author":[{"given":"Barbara","family":"Salzinger","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lundwall","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Evans","sequence":"additional","affiliation":[{"name":"ME Renal Medicine, Department of Clinical Intervention and Technology, Karolinska Institute , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9139-5711","authenticated-orcid":false,"given":"Josefin","family":"M\u00f6rtberg","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Centre for Clinical Research, County of Vastmanland and Uppsala University , Uppsala , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Wall\u00e9n","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Jernberg","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9909-4956","authenticated-orcid":false,"given":"Thomas","family":"Kahan","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Lundman","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Tornvall","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, Sodersjukhuset, Karolinska Institute , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Erlinge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Clinical Sciences, Lund University , Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5795-0061","authenticated-orcid":false,"given":"Bertil","family":"Lindahl","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Cardiology, Uppsala Clinical Research Centre, Uppsala University , Uppsala , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8290-557X","authenticated-orcid":false,"given":"Tomasz","family":"Baron","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Cardiology, Uppsala Clinical Research Centre, Uppsala University , Uppsala , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Rezeli","sequence":"additional","affiliation":[{"name":"Clinical Protein Science & Imaging, Department of Biomedical Engineering, Lund University , Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Spaak","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"2024032214150643800_bib1","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","article-title":"Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes","volume":"106","author":"Al Suwaidi","year":"2002","journal-title":"Circulation"},{"key":"2024032214150643800_bib2","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.ehj.2004.08.016","article-title":"Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials","volume":"25","author":"Gibson","year":"2004","journal-title":"Eur Heart J"},{"key":"2024032214150643800_bib3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/heart.89.9.1003","article-title":"Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE)","volume":"89","author":"Santopinto","year":"2003","journal-title":"Heart"},{"key":"2024032214150643800_bib4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","article-title":"Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)","volume":"120","author":"Szummer","year":"2009","journal-title":"Circulation"},{"key":"2024032214150643800_bib5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"key":"2024032214150643800_bib6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.ackd.2018.08.004","article-title":"Cardiorenal syndrome: an overview","volume":"25","author":"Ronco","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"2024032214150643800_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"2024032214150643800_bib8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"2024032214150643800_bib9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.321752","article-title":"Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease","volume":"132","author":"Baaten","year":"2023","journal-title":"Circ Res"},{"key":"2024032214150643800_bib10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/HYPERTENSIONAHA.117.10648","article-title":"Association of pulse wave velocity with chronic kidney disease progression and mortality: findings from the CRIC Study (Chronic Renal Insufficiency Cohort)","volume":"71","author":"Townsend","year":"2018","journal-title":"Hypertension"},{"key":"2024032214150643800_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/08037051.2022.2064266","article-title":"Aortic stiffness and aortic-brachial stiffness mismatch as markers of renal dysfunction in hypertension","volume":"31","author":"Lundwall","year":"2022","journal-title":"Blood Press"},{"key":"2024032214150643800_bib12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1042\/CS20200279","article-title":"Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity","volume":"134","author":"Querfeld","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"2024032214150643800_bib13","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1093\/nar\/gkr424","article-title":"Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood","volume":"39","author":"Lundberg","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2024032214150643800_bib14","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"2024032214150643800_bib15","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1021\/acs.jproteome.7b00235","article-title":"Quantitation of 87 proteins by nLC-MRM\/MS in human plasma: workflow for large-scale analysis of biobank samples","volume":"16","author":"Rezeli","year":"2017","journal-title":"J Proteome Res"},{"key":"2024032214150643800_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1681\/ASN.2021060747","article-title":"Risk prediction models for atherosclerotic cardiovascular disease in patients with chronic kidney disease: the CRIC Study","volume":"33","author":"Bundy","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"2024032214150643800_bib17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ehjacc\/zuaa014","article-title":"Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers","volume":"10","author":"Eggers","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2024032214150643800_bib18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/hrt.2010.198804","article-title":"The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease evaluated according to recommended therapies (SWEDEHEART)","volume":"96","author":"Jernberg","year":"2010","journal-title":"Heart"},{"key":"2024032214150643800_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12882-019-1261-x","article-title":"Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function \u2013 a descriptive study","volume":"20","author":"M\u00f6rtberg","year":"2019","journal-title":"BMC Nephrol"},{"key":"2024032214150643800_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"2024032214150643800_bib21","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/ndt\/gfh981","article-title":"Renal function, concomitant medication use and outcomes following acute coronary syndromes","volume":"20","author":"Reddan","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2024032214150643800_bib22","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.2215\/CJN.01260210","article-title":"Effect of kidney disease on acute coronary syndrome","volume":"5","author":"Rodrigues","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024032214150643800_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","article-title":"Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study)","volume":"60","author":"Ix","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2024032214150643800_bib24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/heartjnl-2016-310520","article-title":"Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction","volume":"103","author":"Reindl","year":"2017","journal-title":"Heart"},{"key":"2024032214150643800_bib25","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1681\/ASN.2017121334","article-title":"Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: a meta-analysis","volume":"29","author":"Marthi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2024032214150643800_bib26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/ckj\/sfad144","article-title":"The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?","volume":"16","author":"Magagnoli","year":"2023","journal-title":"Clin Kidney J"},{"key":"2024032214150643800_bib27","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2215\/CJN.13631119","article-title":"Fibroblast growth factor 23 and the last mile","volume":"15","author":"Guti\u00e9rrez","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024032214150643800_bib28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1159\/000492244","article-title":"The association of fibroblast growth factor 23 with arterial stiffness and atherosclerosis in patients with autosomal dominant polycystic kidney disease","volume":"43","author":"Coban","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"2024032214150643800_bib29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/joim.13116","article-title":"Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction","volume":"288","author":"Edfors","year":"2020","journal-title":"J Intern Med"},{"key":"2024032214150643800_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ki.2012.327","article-title":"Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community","volume":"83","author":"\u00c4rnl\u00f6v","year":"2013","journal-title":"Kidney Int"},{"key":"2024032214150643800_bib31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MNH.0000000000000631","article-title":"Burosumab in X-linked hypophosphatemia and perspective for chronic kidney disease","volume":"29","author":"Balani","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2024032214150643800_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.clinbiochem.2015.01.006","article-title":"Endocan\u2014the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease","volume":"48","author":"Pawlak","year":"2015","journal-title":"Clin Biochem"},{"key":"2024032214150643800_bib33","doi-asserted-by":"crossref","first-page":"798699","DOI":"10.3389\/fcvm.2021.798699","article-title":"Endocan: a key player of cardiovascular disease","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2024032214150643800_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2500\/aap.2013.34.3646","article-title":"The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity","volume":"34","author":"Li","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"2024032214150643800_bib35","doi-asserted-by":"crossref","first-page":"F517","DOI":"10.1152\/ajprenal.00291.2005","article-title":"Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury","volume":"290","author":"Vaidya","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2024032214150643800_bib36","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/eurjhf\/hfr102","article-title":"Kidney injury molecule-1 and N-acetyl-\u03b2-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome","volume":"13","author":"Jungbauer","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2024032214150643800_bib37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/nep.12632","article-title":"N-acteyl-\u03b2-D-glucosaminidase and kidney injury molecule-1: new predictors for long-term progression of chronic kidney disease in patients with heart failure","volume":"21","author":"Jungbauer","year":"2016","journal-title":"Nephrology"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfae050\/56819219\/sfae050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/3\/sfae050\/57060902\/sfae050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/3\/sfae050\/57060902\/sfae050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T14:16:19Z","timestamp":1711116979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfae050\/7617709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfae050","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2024,3,1]]},"article-number":"sfae050"}}